Aging Population And Robotic Advances Will Unlock Urologic Potential
AN
AnalystHighTarget
Not Invested
Consensus Narrative from 9 Analysts
Published
04 Aug 25
Updated
16 Aug 25
AnalystHighTarget's Fair Value
US$85.00
51.1% undervalued intrinsic discount16 Aug
US$41.59
1Y
-35.7%7D
8.3%